MIG Fonds and Global Asset Management have invested a further €13m in biotechnology company Antisense Pharma GmbH, with management and private investors also taking part in the financing.
Goldman Sachs and Kennet Partners are expected to make a 5x return on their investment in Nuxeo
Acquisition of the cybersecurity and identity firm is backed by BGF and Santander Growth Capital
GP's backing will help the company expand its service, delivery capability, and product range
Company plans to use the financing to expand its portfolio of drugs and grow its artificial intelligence capabilities